Compound 1139
Identifiers
- Canonical SMILES:
CCCn1cc(C(=O)C(=O)N2CCN(CC2)C(=O)c2ccccc2)c2ccccc12
- InChi:
InChI=1S/C24H25N3O3/c1-2-12-27-17-20(19-10-6-7-11-21(19)27)22(28)24(30)26-15-13-25(14-16-26)23(29)18-8-4-3-5-9-18/h3-11,17H,2,12-16H2,1H3
- InChiKey:
UBRAAHQOJHKSBF-UHFFFAOYSA-N
External links
![]() 168317897 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
0 | 1 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
CD4 / gp120 | 5.58 | HIV infectious disease | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 403.19 g/mol | |||
HBA | 6 | |||
HBD | 0 | |||
HBA + HBD | 6 | |||
AlogP | 3.26 | |||
TPSA | 62.62 | |||
RB | 5 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 0 | 1 | 0 | 0 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.7482 | Talmapimod | DB05412 | |
0.7097 | LY-517717 | DB05713 | |
0.6866 | Indibulin | DB06169 | |
0.6667 | Indoramin | DB08950 | |
0.6471 | LTX-315 | DB12748 | |
0.6389 | 5-METHYL-3-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.013,18]NONADECA-12(19),13,15,17-TETRAEN-10-YLCARBAMOYL)-HEXANOIC ACID | DB08493 | |
0.6356 | N-[1H-INDOL-3-YL-ACETYL]GLYCINE ACID | DB07952 | |
0.6350 | Gramicidin D | DB00027 | |
0.6345 | N4-HYDROXY-2-ISOBUTYL-N1-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.013,18]NONADECA-12(19),13,15,17-TETRAEN-10-YL)-SUCCINAMIDE | DB08489 | |
0.6304 | Tivantinib | DB12200 | |
0.6179 | N-[1H-INDOL-3-YL-ACETYL]VALINE ACID | DB07953 | |
0.6096 | Omiganan | DB06610 | |
0.6043 | Macimorelin | DB13074 | |
0.5972 | Ilomastat | DB02255 | |
0.5946 | Somatoprim | DB12777 |